BUSINESS WIRE

TriLink BioTechnologies® kündigt neue Anlage in San Diego zur mRNA-Produktion von Arzneimittelwirkstoffen in der Spätphase an

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)
TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)
In voller Größe anschauen Opens in new window

Download-Formate